OXBRYTA Trademark

Trademark Overview

On Friday, May 3, 2019, a trademark application was filed for OXBRYTA with the United States Patent and Trademark Office. The USPTO has given the OXBRYTA trademark a serial number of 88415216. The federal status of this trademark filing is REGISTERED as of Tuesday, February 11, 2020. This trademark is owned by Global Blood Therapeutics, Inc.. The OXBRYTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
oxbryta

General Information

Serial Number88415216
Word MarkOXBRYTA
Filing DateFriday, May 3, 2019
Status700 - REGISTERED
Status DateTuesday, February 11, 2020
Registration Number5986299
Registration DateTuesday, February 11, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 20, 2019

Trademark Statements

Description of MarkThe mark consists of the word "OXBRYTA" with a design of dots forming a circle around the letter "O".
Goods and ServicesPharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 23, 2019
Primary Code005
First Use Anywhere DateTuesday, December 17, 2019
First Use In Commerce DateTuesday, December 17, 2019

Trademark Owner History

Party NameGlobal Blood Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGlobal Blood Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGlobal Blood Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, May 7, 2019NEW APPLICATION ENTERED
Thursday, May 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 20, 2019PUBLISHED FOR OPPOSITION
Friday, May 24, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, July 16, 2019ASSIGNED TO EXAMINER
Wednesday, July 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 31, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 20, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 15, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 17, 2019USE AMENDMENT FILED
Tuesday, December 17, 2019TEAS STATEMENT OF USE RECEIVED
Saturday, December 28, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, December 28, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, January 6, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 7, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 11, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, September 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 10, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, November 17, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 4, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 17, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 17, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 17, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 17, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 11, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

oxbryta treatment preparations pharmaceutical hypoxic conditions disease hypoxemic such hematological disorders